Izaskun Buendía

3.5k total citations · 1 hit paper
41 papers, 2.7k citations indexed

About

Izaskun Buendía is a scholar working on Molecular Biology, Neurology and Physiology. According to data from OpenAlex, Izaskun Buendía has authored 41 papers receiving a total of 2.7k indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Molecular Biology, 13 papers in Neurology and 13 papers in Physiology. Recurrent topics in Izaskun Buendía's work include Neuroinflammation and Neurodegeneration Mechanisms (12 papers), Genomics, phytochemicals, and oxidative stress (8 papers) and Alzheimer's disease research and treatments (8 papers). Izaskun Buendía is often cited by papers focused on Neuroinflammation and Neurodegeneration Mechanisms (12 papers), Genomics, phytochemicals, and oxidative stress (8 papers) and Alzheimer's disease research and treatments (8 papers). Izaskun Buendía collaborates with scholars based in Spain, France and United States. Izaskun Buendía's co-authors include Javier Egea, Rafael León, Elisa Navarro, Manuela G. López, Patrycja Michalska, Esther Parada, Isabel Gameiro‐Ros, Antonio Cuadrado, Pilar Negredo and Kenzo Koizumi and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Nature Communications and Nature Neuroscience.

In The Last Decade

Izaskun Buendía

41 papers receiving 2.7k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Nrf2–ARE pathway: An emerging target against oxidative stress and neuroinflammation in neurodegenerative diseases

2015 537 citations Izaskun Buendía, Patrycja Michalska et al. Pharmacology & Therapeutics profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Izaskun Buendía Spain	26	1.3k	727	525	345	310	41	2.7k
Fawad Ali Shah Pakistan	31	963 0.8×	615 0.8×	374 0.7×	210 0.6×	523 1.7×	103	2.9k
Zaijun Zhang China	35	1.6k 1.3×	679 0.9×	709 1.4×	529 1.5×	264 0.9×	151	4.0k
Nadia G. Innamorato Spain	10	1.5k 1.2×	573 0.8×	346 0.7×	527 1.5×	312 1.0×	10	2.5k
Tahir Ali South Korea	30	1.2k 1.0×	819 1.1×	1.1k 2.1×	401 1.2×	454 1.5×	60	3.5k
Phil‐Ok Koh South Korea	32	1.2k 1.0×	748 1.0×	528 1.0×	212 0.6×	146 0.5×	151	3.1k
Hao Hong China	28	1.0k 0.8×	614 0.8×	770 1.5×	317 0.9×	242 0.8×	58	2.6k
Elisa Navarro Spain	17	944 0.8×	686 0.9×	343 0.7×	204 0.6×	324 1.0×	33	2.1k
Shyam Sunder Sharma India	35	1.5k 1.2×	563 0.8×	1.3k 2.5×	305 0.9×	156 0.5×	141	4.4k
Mohammad Badruzzaman Khan United States	32	971 0.8×	859 1.2×	762 1.5×	496 1.4×	125 0.4×	72	3.6k
Seung‐Hwan Kwon South Korea	31	1.3k 1.0×	589 0.8×	861 1.6×	405 1.2×	217 0.7×	62	3.6k

Countries citing papers authored by Izaskun Buendía

Since Specialization

Citations

This map shows the geographic impact of Izaskun Buendía's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Izaskun Buendía with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Izaskun Buendía more than expected).

Fields of papers citing papers by Izaskun Buendía

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Izaskun Buendía. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Izaskun Buendía. The network helps show where Izaskun Buendía may publish in the future.

Co-authorship network of co-authors of Izaskun Buendía

This figure shows the co-authorship network connecting the top 25 collaborators of Izaskun Buendía. A scholar is included among the top collaborators of Izaskun Buendía based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Izaskun Buendía. Izaskun Buendía is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

1.

Buendía, Izaskun, Vanessa Ginet, Eloïse Lemarchand, et al.. (2021). Thrombolysis by PLAT/tPA increases serum free IGF1 leading to a decrease of deleterious autophagy following brain ischemia. Autophagy. 18(6). 1297–1317. 20 indexed citations

2.

Levard, Damien, et al.. (2020). Filling the gaps on stroke research: Focus on inflammation and immunity. Brain Behavior and Immunity. 91. 649–667. 74 indexed citations

3.

Michalska, Patrycja, Izaskun Buendía, Pablo Duarte, et al.. (2019). Melatonin-sulforaphane hybrid ITH12674 attenuates glial response in vivo by blocking LPS binding to MD2 and receptor oligomerization. Pharmacological Research. 152. 104597–104597. 19 indexed citations

4.

Martin‐de‐Saavedra, María Dolores, Elisa Navarro, Maurício P. Cunha, et al.. (2018). The APPswe/PS1A246E mutations in an astrocytic cell line leads to increased vulnerability to oxygen and glucose deprivation, Ca²⁺ dysregulation, and mitochondrial abnormalities. Journal of Neurochemistry. 145(2). 170–182. 6 indexed citations

5.

Koizumi, Kenzo, Yorito Hattori, Sung Ji Ahn, et al.. (2018). Apoε4 disrupts neurovascular regulation and undermines white matter integrity and cognitive function. Nature Communications. 9(1). 3816–3816. 114 indexed citations

6.

Rojo, Ana I., Marta Pajares, Ángel J. García‐Yagüe, et al.. (2018). Deficiency in the transcription factor NRF2 worsens inflammatory parameters in a mouse model with combined tauopathy and amyloidopathy.. 2 indexed citations

7.

Rojo, Ana I., Marta Pajares, Ángel J. García‐Yagüe, et al.. (2018). Deficiency in the transcription factor NRF2 worsens inflammatory parameters in a mouse model with combined tauopathy and amyloidopathy. Redox Biology. 18. 173–180. 87 indexed citations

8.

Hernansanz‐Agustín, Pablo, Elena Ramos, Elisa Navarro, et al.. (2017). Mitochondrial complex I deactivation is related to superoxide production in acute hypoxia. Redox Biology. 12. 1040–1051. 105 indexed citations

9.

Gameiro‐Ros, Isabel, Patrycja Michalska, Giammarco Tenti, et al.. (2017). Discovery of the first dual GSK3β inhibitor/Nrf2 inducer. A new multitarget therapeutic strategy for Alzheimer’s disease. Scientific Reports. 7(1). 45701–45701. 70 indexed citations

10.

Fernández‐Mendívil, Cristina, Patrycja Michalska, Izaskun Buendía, et al.. (2016). Novel sulfoglycolipid IG20 causes neuroprotection by activating the phase II antioxidant response in rat hippocampal slices. Neuropharmacology. 116. 110–121. 2 indexed citations

11.

Michalska, Patrycja, Izaskun Buendía, Laura Barrio, & Rafael León. (2016). Novel Multitarget Hybrid Compounds for the Treatment of Alzheimer’s Disease. Current Topics in Medicinal Chemistry. 17(9). 1027–1043. 18 indexed citations

12.

Benchekroun, Mohamed, Alejandro Romero, Javier Egea, et al.. (2016). The Antioxidant Additive Approach for Alzheimer’s Disease Therapy: New Ferulic (Lipoic) Acid Plus Melatonin Modified Tacrines as Cholinesterases Inhibitors, Direct Antioxidants, and Nuclear Factor (Erythroid-Derived 2)-Like 2 Activators. Journal of Medicinal Chemistry. 59(21). 9967–9973. 89 indexed citations

13.

Rieger, Débora Kurrle, Elisa Navarro, Izaskun Buendía, et al.. (2016). ConBr, A Lectin Purified from the Seeds of Canavalia brasiliensis, Protects Against Ischemia in Organotypic Culture of Rat Hippocampus: Potential Implication of Voltage-Gated Calcium Channels. Neurochemical Research. 42(2). 347–359. 3 indexed citations

14.

Navarro, Elisa, Laura González‐Lafuente, Izaskun Buendía, et al.. (2016). Heme-Oxygenase I and PCG-1α Regulate Mitochondrial Biogenesis via Microglial Activation of Alpha7 Nicotinic Acetylcholine Receptors Using PNU282987. Antioxidants and Redox Signaling. 27(2). 93–105. 68 indexed citations

15.

Buendía, Izaskun, et al.. (2016). Sensory Input-Dependent Changes in Glutamatergic Neurotransmission- Related Genes and Proteins in the Adult Rat Trigeminal Ganglion. Frontiers in Molecular Neuroscience. 9. 132–132. 10 indexed citations

16.

Buendía, Izaskun, Vanessa Gómez‐Rangel, Laura González‐Lafuente, et al.. (2015). Neuroprotective mechanism of the novel melatonin derivative Neu-P11 in brain ischemia related models. Neuropharmacology. 99. 187–195. 34 indexed citations

17.

Freitas, Andiara E., Javier Egea, Izaskun Buendía, et al.. (2015). Agmatine, by Improving Neuroplasticity Markers and Inducing Nrf2, Prevents Corticosterone-Induced Depressive-Like Behavior in Mice. Molecular Neurobiology. 53(5). 3030–3045. 89 indexed citations

18.

Buendía, Izaskun, Patrycja Michalska, Elisa Navarro, et al.. (2015). Nrf2–ARE pathway: An emerging target against oxidative stress and neuroinflammation in neurodegenerative diseases. Pharmacology & Therapeutics. 157. 84–104. 537 indexed citations breakdown →

19.

Freitas, Andiara E., Javier Egea, Izaskun Buendía, et al.. (2014). Agmatine Induces Nrf2 and Protects Against Corticosterone Effects in Hippocampal Neuronal Cell Line. Molecular Neurobiology. 51(3). 1504–1519. 57 indexed citations

20.

Egea, Javier, E. Parada, Vanessa Gómez‐Rangel, et al.. (2014). Small synthetic hyaluronan disaccharides afford neuroprotection in brain ischemia-related models. Neuroscience. 265. 313–322. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact